Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Bharat Biotech grants Rs 172 crore royalty to ICMR from Covaxin sale

Ruchika Sharma9 Feb 2022 12:28 PM IST

New Delhi: Pharma major Bharat Biotech has recently given the royalty of Rs 171.74 crore to the Indian Council of Medical Research (ICMR) from...

Lupin bags USFDA nod for generic equivalent of Brovana Inhalation Solution

Ruchika Sharma9 Feb 2022 11:52 AM IST

Mumbai: Global pharma major Lupin Limited has recently announced that the company has received approval from the United States Food and Drug...

COVID-19: Glenmark launches FabiSpray in India

Ruchika Sharma9 Feb 2022 11:26 AM IST

FabiSpray, Nitric Oxide Nasal Spray, is designed to kill the COVID-19 virus in the upper airways.

Piramal Pharma Solutions expands, upgrades UK facilities

Ruchika Sharma9 Feb 2022 11:00 AM IST

Mumbai: Piramal Pharma Limited's Pharma Solutions business, a Contract Development and Manufacturing Organization (CDMO), has announced the expansion...

JnJ pauses production of its COVID vaccine

Ruchika Sharma9 Feb 2022 10:30 AM IST

New Delhi: Johnson & Johnson late last year quietly shut down the only plant making usable batches of its COVID-19 vaccine, the New York Times...

COVID vaccines pushes Pfizer beyond expectations in final quarter

Ruchika Sharma9 Feb 2022 9:30 AM IST

Washington: COVID-19 vaccine sales boosted Pfizer earnings well past analyst expectations in the final quarter of 2021, but the drugmaker is setting a...

Biocon arm bags USFDA approval for Posaconazole Delayed-Release tablets

Ruchika Sharma8 Feb 2022 5:07 PM IST

Bangalore: Biocon Pharma Limited, a subsidiary of Biocon Limited, has recently announced that the company has received approval of its...

CDSCO nod to Wockhardt for exporting up to 100 million Sputnik doses

Ruchika Sharma8 Feb 2022 3:30 PM IST

Mumbai: Wockhardt Limited, a global Pharmaceutical and Biotechnology Company headquartered in India, on Tuesday said that it has received permission...

SII proposal to manufacture Omicron vaccine for analysis gets DCGI nod

Ruchika Sharma8 Feb 2022 12:06 PM IST

New Delhi: The Drugs Controller General of India (DCGI) has approved Serum Institute of India's proposal to manufacture a vaccine against omicron...

Sanofi Enjaymo gets USFDA okay for cold agglutinin disease

Ruchika Sharma8 Feb 2022 11:43 AM IST

The US list price, or wholesale acquisition cost, of Enjaymo is $1,800 per vial.

Pfizer India ropes in Pradip Shah as Chairman

Ruchika Sharma8 Feb 2022 11:00 AM IST

New Delhi: Pfizer India has recently announced the appointment of Pradip Shah, Independent Director as the Chairman of the Board of Directors of the...

Azurity Pharma gets USFDA nod for FLEQSUVY

Ruchika Sharma8 Feb 2022 10:00 AM IST

Woburn: Azurity Pharmaceuticals, a private specialty pharmaceutical company, has recently announced the U.S. Food and Drug Administration (USFDA)...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok